Login / Signup

The Outcome of Antifungal Prophylaxis with Posaconazole in Patients with Acute Myeloid Leukemia: A Single-Center Study

Vildan ÖzkocamazFahir ÖzkalemkaşSerdar SeyhanBeyza EnerAhmet UrsavaşTuba ErsalEsra KazakEzgi Demirdöğen ÇetinoğluReşit MıstıkEmin Halis Akalın
Published in: Turkish journal of haematology : official journal of Turkish Society of Haematology (2018)
Posaconazole appears to be effective and well-tolerated protection against IFIs for AML patients.
Keyphrases
  • acute myeloid leukemia
  • end stage renal disease
  • newly diagnosed
  • chronic kidney disease
  • prognostic factors
  • peritoneal dialysis
  • patient reported outcomes
  • patient reported